Ariad Pharmaceuticals Inc (NASDAQ:ARIA)

CAPS Rating: 3 out of 5

The Company is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules.

Recs

0
Player Avatar TerryFool (< 20) Submitted: 3/29/2014 9:43:29 PM : Outperform Start Price: $7.51 ARIA Score: -30.82

TRADE BUY@ 7.5 TP 11

Featured Broker Partners


Advertisement